This is an old revision of this page, as edited by Rjwilmsi (talk | contribs) at 17:14, 12 February 2011 (clean up (DOI links) using AWB (7584)). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 17:14, 12 February 2011 by Rjwilmsi (talk | contribs) (clean up (DOI links) using AWB (7584))(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compound | |
| Clinical data | |
|---|---|
| ATC code |
|
| Identifiers | |
IUPAC name
| |
| CAS Number | |
| PubChem CID | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H18F2N6O7S2 |
| Molar mass | 496.46 g/mol g·mol |
Flomoxef (INN) is an oxacephem antibiotic.
It has been identified as second-generation and fourth generation.
References
- Masuda Z, Kurosaki Y, Ishino K, Yamauchi K, Sano S (2008). "Pharmacokinetic analysis of flomoxef in children undergoing cardiopulmonary bypass and modified ultrafiltration". Gen Thorac Cardiovasc Surg. 56 (4): 163–9. doi:10.1007/s11748-007-0208-5. PMID 18401677.
{{cite journal}}: Unknown parameter|month=ignored (help)CS1 maint: multiple names: authors list (link) - Ito M, Ishigami T (1991). "The meaning of the development of flomoxef and clinical experience in Japan". Infection. 19 Suppl 5: S253–7. PMID 1783441.
 | This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |